5649-38-7

Usage

Substituents

Chlorine at 6-position, amino group at 2-position

Common Use

Photoinitiator in industries such as adhesives, coatings, and printing inks

Function

Initiates photopolymerization process by absorbing light and undergoing chemical reaction

Applications

Used for creating polymers in various industrial processes

Research Interest

Studied for potential applications in organic electronics and materials science

Properties

Known for its photochemical and electrochemical properties

Safety Precautions

Proper handling and safety measures recommended when working with the compound

Upstream product

• 6575-11-7 2-amino-6-chlorobenzonitrile 
• 100-58-3 phenylmagnesium bromide 

Downstream Products

• 116690-69-8 6-chloro-10-phenyl-1,2,3,4-tetrahydroacridine 
• 91713-76-7 7-benzoyl-6-chloro-1,3-dihydro-2H-indol-2-one 
• 51478-46-7 6-chloro-2-amino-3,4-diphenylquinoline 
• 4015-30-9 5-chloro-4-phenylquinazoline 
• 91714-80-6 Sodium; (2-amino-3-benzoyl-4-chloro-phenyl)-acetate 
• 91713-75-6 7-Benzoyl-6-chloro-3-methylsulfanyl-1,3-dihydro-indol-2-one 

Relevant academic research and scientific papers

Silver-Catalyzed Isocyanide Insertion into N?H Bond of Ammonia: [5+1] Annulation to Quinazoline Derivatives

A silver-catalyzed [5+1] annulation of o-acylaryl isocyanides with ammonium acetate and hydroxlamine was developed for the efficient and practical synthesis of quinazolines and quinazoline 3-oxides in good to excellent yields, respectively. The domino process involved an unprecedented isocyanide insertion into the N?H bond of ammonia or hydroxylamine and followed by condensation reaction at ambient conditions. (Figure presented.).

Substituted tetracyclic azepine derivatives

This invention concerns the compounds of formula (I), the pharmaceutically acceptable salts and stereoisomeric forms thereof, and also the N-oxide forms thereof. STR1 wherein: R1 and R2 each independently are hydrogen; C1-6 alkyl; C1-6 alkylcarbonyl; trihalomethylcarbonyl; C1-6 alkyl substituted with hydroxy, C1-6 alkyloxy, carboxyl, C1-6 alkylcarbonyloxy, C1-6 alkyloxycarbonyl or aryl; or R1 and R2 taken together with the nitrogen atom to which they are attached may form a morpholinyl ring or an optionally substituted heterocycle; R3, R4, R5, R6, R9, R10, R11 or R12 each independently are hydrogen, halo, cyano, hydroxy, trifluoromethyl, trifluoromethoxy, carboxyl, nitro, amino, mono- or di(C1-6 alkyl)-amino, C1-6 alkylcarbonylamino, aminosulfonyl, mono- or di(C1-6 alkyl)-aminosulfonyl, C1-6 alkyl, C1-6 alkyloxy, C1-6 alkylcarbonyl, C1-6 alkyloxy-carbonyl; R7 and R8 are each independently hydrogen, hydroxy, C1-6 alkyl, C1-6 alkyloxy or R7 and R8 taken together may form mono- or di(cyano)methylene, or together with the carbon atom to which they are attached form a carbonyl or a spiro substituent; or R7 and R8 taken together may form methylene; R13 is hydrogen, C1-6 alkyl, or trifluoromethyl; R14 is hydrogen, C1-6 alkyl, cyano, or trifluoromethyl; n is zero to 6. These compounds were tested as mCPP-antagonists in rats. The compounds of formula (I) may be used as therapeutic agents in the treatment or the prevention of CNS disorders, cardiovascular disorders or gastrointestinal disorders.